Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30
Reach urologists

Topical triamcinolone for persistent phimosis - Abstract Show Comments PDF Print E-mail
  
Wednesday, 04 November 2009

Department of Surgery, Division of Pediatric Urology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montreal, Montreal, Quebec, Canada.

Between 2% and 5% of uncircumcised boys have persistent or pathological phimosis. Traditional treatment is usually circumcision. Recently medical treatment with topical corticosteroids has become more popular. We evaluated the efficacy of the topical steroid triamcinolone compared to foreskin retraction with an emollient cream and verified the long-term success rate of these treatments.

We performed a double-blind, randomized, placebo controlled study to compare 2-month twice daily treatment with emollient cream (placebo group 1) vs 0.1% triamcinolone (experimental group 2). Boys between ages 3 and 12 years with persistent or pathological phimosis were included in analysis. Study EXCLUSION criteria were previous treatment with topical corticosteroid, untreated balanitis and any known medical condition with immune system impairment. Patients were seen 2, 4 and 12 months after treatment initiation. Success was defined as complete, easy foreskin retraction at 4 and 12 months. Statistical analysis was done using Fisher's exact test.

We enrolled 63 patients, of whom 43 completed the study. Despite multiple attempts 20 patients had incomplete followup and were excluded from study. Placebo group 1 included 25 patients and triamcinolone group 2 included 21. In group 1 the success rate was significantly lower than in group 2 (9 patients or 39% vs 16 or 76%, p = 0.0086). At 2 months 5 and 16 nonresponders in groups 2 and 1, respectively, were treated in nonblinded fashion with topical triamcinolone. In this subgroup 1 of 3 group 2 patients and 6 of 13 in group 1 achieved complete, easy retraction. Two and 1 patients were lost to followup in groups 1 and 2, respectively. Circumcision was required in only 5 patients (11.6%), including 4 (17.4%) initially in group 1. No complications were noted in either group.

Triamcinolone is a highly effective and safe short-term treatment for persistent physiological or pathological phimosis. However, at long-term followup recurrence is frequent and not rare with triamcinolone and it may require re-treatment or circumcision.

Written by:
Letendre J, Barrieras D, Franc-Guimond J, Abdo A, Houle AM.   Are you the author?

Reference:
J Urol. 2009 Oct;182(4 Suppl):1759-63.
doi:10.1016/j.juro.2009.03.016

PubMed Abstract
PMID:19692044

UroToday.com Pediatric Urology Section

Reader Comments
Phimosis cannot be diagnosed before pube
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2009-11-05 11:05:20
This is a rather shocking article. According to Oster (1968) and Kayaba (1996) as well as numerous other articles, pathological phimosis cannot be truly diagnosed until late puberty. Indeed it is not until 10.5 years that 50% of boys have a fully retractable foreskin. See www.cirp.org/library/normal. So it should be no surprise that the treatment is often only temporarily effective in boys from 3 to 12. Why all this worry about early retractability? Phimosis is only a worry if the urine stream is truly blocked or if the young man reaches early adulthood without full retractability. Even then some may take into their 20s to fully develop.

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 7
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
2 (1 votes)

Patients:
2 (6 votes)

No Affiliation:
4 (5 votes)


Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Pediatric Urology
Sponsored By